Timelines / Regeneron Pharmaceuticals Regeneron Pharmaceuticals Regeneron Pharmaceuticals' timeline holds 513 claims from 1988 to 2026: 1 people, 504 money & deals, 8 other. 7 are undated. The latest took effect on September 30, 2026 .
Newest first, 23 years; a claim a later one replaced stays on the line, struck through. Current state →
Facts: CEO · headquarters · revenue · net income · operating income · quarterly revenue · across every company: ceos , headquarters , revenue , net income , quarterly revenue
By year
September · 7 2026-09-30 sec.gov, 1 source, claim clm_5EBA4C72A92F cash and equivalents 3,659,100,000 United States dollar 2026-09-30 sec.gov, 1 source, claim clm_DEF587D6916A quarterly net income 1,948,700,000 United States dollar 2026-09-30 sec.gov, 1 source, claim clm_4585DB96888D quarterly operating income 2,048,200,000 United States dollar 2026-09-30 sec.gov, 1 source, claim clm_4D8C13296D0A quarterly research and development 1,794,700,000 United States dollar 2026-09-30 sec.gov, 1 source, claim clm_15BDC7B1496E quarterly revenue 5,115,800,000 United States dollar 2026-09-30 sec.gov, 1 source, claim clm_F46BE3EF6472 total assets 44,405,200,000 United States dollar 2026-09-30 sec.gov, 1 source, claim clm_24A29A7153C0 total equity 33,498,500,000 United States dollar June · 7 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_6D7C70396974 cash and equivalents 2,455,800,000 United States dollar (replaced) 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_6178480D55DF quarterly net income 1,296,900,000 United States dollar (replaced) 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_2721EF4559B5 quarterly operating income 1,293,500,000 United States dollar (replaced) 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_223E08E3A074 quarterly research and development 1,631,600,000 United States dollar (replaced) 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_11098E7F99BC quarterly revenue 4,290,700,000 United States dollar (replaced) 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_0A911086D51B total assets 41,730,600,000 United States dollar (replaced) 2026-06-30 to 2026-09-30 sec.gov, 1 source, claim clm_B9E0E558C863 total equity 31,711,400,000 United States dollar (replaced) March · 7 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_518E1E5FF285 cash and equivalents 2,962,600,000 United States dollar (replaced) 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_55728063B1D6 quarterly net income 727,200,000 United States dollar (replaced) 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_6BF4C3658A74 quarterly operating income 642,900,000 United States dollar (replaced) 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_D76E4D0088C5 quarterly research and development 1,543,500,000 United States dollar (replaced) 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_89291214D4AA quarterly revenue 3,605,400,000 United States dollar (replaced) 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_81C2322B5ECE total assets 40,868,800,000 United States dollar (replaced) 2026-03-31 to 2026-06-30 sec.gov, 1 source, claim clm_98A5851FED3C total equity 31,423,600,000 United States dollar (replaced) December · 7 2025-12-31 to 2026-03-31 sec.gov, 1 source, claim clm_B18C1963BC40 cash and equivalents 3,118,100,000 United States dollar (replaced) 2025-12-31 sec.gov, 1 source, claim clm_7514724ED5E9 net income 4,504,900,000 United States dollar 2025-12-31 sec.gov, 1 source, claim clm_1B456AFB0CC5 operating income 3,577,900,000 United States dollar 2025-12-31 sec.gov, 1 source, claim clm_1819F20C7CC4 research and development 5,850,200,000 United States dollar 2025-12-31 sec.gov, 1 source, claim clm_E5421E95D3E6 revenue 14,342,900,000 United States dollar 2025-12-31 to 2026-03-31 sec.gov, 1 source, claim clm_CFD74D844717 total assets 40,558,700,000 United States dollar (replaced) 2025-12-31 to 2026-03-31 sec.gov, 1 source, claim clm_68C522C0BDED total equity 31,256,900,000 United States dollar (replaced) September · 7 2025-09-30 to 2025-12-31 sec.gov, 1 source, claim clm_5CC511D1F933 cash and equivalents 2,506,400,000 United States dollar (replaced) 2025-09-30 to 2026-03-31 sec.gov, 1 source, claim clm_75B9586D5FEE quarterly net income 1,460,000,000 United States dollar (replaced) 2025-09-30 to 2026-03-31 sec.gov, 1 source, claim clm_0F41A2F44A01 quarterly operating income 1,026,800,000 United States dollar (replaced) 2025-09-30 to 2026-03-31 sec.gov, 1 source, claim clm_F00F9DA4362C quarterly research and development 1,475,000,000 United States dollar (replaced) 2025-09-30 to 2026-03-31 sec.gov, 1 source, claim clm_471EC2DBAE0B quarterly revenue 3,754,300,000 United States dollar (replaced) 2025-09-30 to 2025-12-31 sec.gov, 1 source, claim clm_A47C41C5A48C total assets 40,169,400,000 United States dollar (replaced) 2025-09-30 to 2025-12-31 sec.gov, 1 source, claim clm_CF9BA729AF1E total equity 30,957,800,000 United States dollar (replaced) June · 7 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_436CC0AE1280 cash and equivalents 1,995,800,000 United States dollar (replaced) 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_80007FEE76CE quarterly net income 1,391,600,000 United States dollar (replaced) 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_0CA4006DEF0C quarterly operating income 1,079,500,000 United States dollar (replaced) 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_7D676D307920 quarterly research and development 1,421,700,000 United States dollar (replaced) 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_43E679905BB9 quarterly revenue 3,675,600,000 United States dollar (replaced) 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_0BB82D220F7E total assets 38,219,200,000 United States dollar (replaced) 2025-06-30 to 2025-09-30 sec.gov, 1 source, claim clm_4D236E01F288 total equity 29,938,900,000 United States dollar (replaced) March · 7 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_775D46B7A29F cash and equivalents 3,090,200,000 United States dollar (replaced) 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_65FFF2CBF333 quarterly net income 808,700,000 United States dollar (replaced) 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_3F78C327F519 quarterly operating income 591,700,000 United States dollar (replaced) 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_4BF4BD70527E quarterly research and development 1,327,400,000 United States dollar (replaced) 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_04C1A63A27E9 quarterly revenue 3,028,700,000 United States dollar (replaced) 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_DADAA2FC572E total assets 37,545,200,000 United States dollar (replaced) 2025-03-31 to 2025-06-30 sec.gov, 1 source, claim clm_B1CBF863516B total equity 29,387,600,000 United States dollar (replaced) December · 7 2024-12-31 to 2025-03-31 sec.gov, 1 source, claim clm_F0F5921A0058 cash and equivalents 2,488,200,000 United States dollar (replaced) 2024-12-31 to 2025-12-31 sec.gov, 1 source, claim clm_4E27594C511A net income 4,412,600,000 United States dollar (replaced) 2024-12-31 to 2025-12-31 sec.gov, 1 source, claim clm_398CD3D76930 operating income 3,990,700,000 United States dollar (replaced) 2024-12-31 to 2025-12-31 sec.gov, 1 source, claim clm_C301E7CAF361 research and development 5,132,000,000 United States dollar (replaced) 2024-12-31 to 2025-12-31 sec.gov, 1 source, claim clm_EE95AAD2339E revenue 14,202,000,000 United States dollar (replaced) 2024-12-31 to 2025-03-31 sec.gov, 1 source, claim clm_428AF772B422 total assets 37,759,400,000 United States dollar (replaced) 2024-12-31 to 2025-03-31 sec.gov, 1 source, claim clm_3F5BAE27E768 total equity 29,353,600,000 United States dollar (replaced) September · 7 2024-09-30 to 2024-12-31 sec.gov, 1 source, claim clm_616C3B8DE457 cash and equivalents 2,011,800,000 United States dollar (replaced) 2024-09-30 to 2025-03-31 sec.gov, 1 source, claim clm_B2193D668623 quarterly net income 1,340,600,000 United States dollar (replaced) 2024-09-30 to 2025-03-31 sec.gov, 1 source, claim clm_EB508637D538 quarterly operating income 1,179,500,000 United States dollar (replaced) 2024-09-30 to 2025-03-31 sec.gov, 1 source, claim clm_61BE04D629BB quarterly research and development 1,271,500,000 United States dollar (replaced) 2024-09-30 to 2025-03-31 sec.gov, 1 source, claim clm_A6AD04E866B3 quarterly revenue 3,720,700,000 United States dollar (replaced) 2024-09-30 to 2024-12-31 sec.gov, 1 source, claim clm_58CF60C9C3BB total assets 37,441,900,000 United States dollar (replaced) 2024-09-30 to 2024-12-31 sec.gov, 1 source, claim clm_F515E2AB009D total equity 29,325,900,000 United States dollar (replaced) June · 7 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_B12373EE7B0C cash and equivalents 1,920,700,000 United States dollar (replaced) 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_01E985023556 quarterly net income 1,432,300,000 United States dollar (replaced) 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_9B13454F52AA quarterly operating income 1,069,600,000 United States dollar (replaced) 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_6410B4B55A22 quarterly research and development 1,200,000,000 United States dollar (replaced) 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_3891C0E928C4 quarterly revenue 3,547,100,000 United States dollar (replaced) 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_567F86365DD5 total assets 36,086,800,000 United States dollar (replaced) 2024-06-30 to 2024-09-30 sec.gov, 1 source, claim clm_E2B4233513FC total equity 28,205,800,000 United States dollar (replaced) March · 7 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_BB705899FBD2 cash and equivalents 2,602,000,000 United States dollar (replaced) 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_D6451915A936 quarterly net income 722,000,000 United States dollar (replaced) 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_5DA47B349189 quarterly operating income 751,400,000 United States dollar (replaced) 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_833AAF046462 quarterly research and development 1,248,400,000 United States dollar (replaced) 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_A39660FD9A27 quarterly revenue 3,145,000,000 United States dollar (replaced) 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_89235EAA3408 total assets 34,369,600,000 United States dollar (replaced) 2024-03-31 to 2024-06-30 sec.gov, 1 source, claim clm_792E7538AC26 total equity 26,991,100,000 United States dollar (replaced) December · 7 2023-12-31 to 2024-03-31 sec.gov, 1 source, claim clm_65E6ADFD0D80 cash and equivalents 2,730,000,000 United States dollar (replaced) 2023-12-31 to 2024-12-31 sec.gov, 1 source, claim clm_11400CA0B8A6 net income 3,953,600,000 United States dollar (replaced) 2023-12-31 to 2024-12-31 sec.gov, 1 source, claim clm_5B0035249BB7 operating income 4,047,100,000 United States dollar (replaced) 2023-12-31 to 2024-12-31 sec.gov, 1 source, claim clm_5546754D63D6 research and development 4,439,000,000 United States dollar (replaced) 2023-12-31 to 2024-12-31 sec.gov, 1 source, claim clm_0A05777F6B3A revenue 13,117,200,000 United States dollar (replaced) 2023-12-31 to 2024-03-31 sec.gov, 1 source, claim clm_24DDC4DBA718 total assets 33,080,200,000 United States dollar (replaced) 2023-12-31 to 2024-03-31 sec.gov, 1 source, claim clm_FF328F070B8B total equity 25,973,100,000 United States dollar (replaced) September · 7 2023-09-30 to 2023-12-31 sec.gov, 1 source, claim clm_FD93D07E05CD cash and equivalents 2,152,300,000 United States dollar (replaced) 2023-09-30 to 2024-03-31 sec.gov, 1 source, claim clm_0089CAC97396 quarterly net income 1,007,800,000 United States dollar (replaced) 2023-09-30 to 2024-03-31 sec.gov, 1 source, claim clm_D79F18FC7528 quarterly operating income 1,111,000,000 United States dollar (replaced) 2023-09-30 to 2024-03-31 sec.gov, 1 source, claim clm_5C3B864B89C2 quarterly research and development 1,075,300,000 United States dollar (replaced) 2023-09-30 to 2024-03-31 sec.gov, 1 source, claim clm_D14890ED012F quarterly revenue 3,362,700,000 United States dollar (replaced) 2023-09-30 to 2023-12-31 sec.gov, 1 source, claim clm_924A6CAD98A4 total assets 32,163,300,000 United States dollar (replaced) 2023-09-30 to 2023-12-31 sec.gov, 1 source, claim clm_426EFFDCB275 total equity 24,904,400,000 United States dollar (replaced) June · 7 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_F903F28AA80F cash and equivalents 1,937,200,000 United States dollar (replaced) 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_0598850A1A59 quarterly net income 968,400,000 United States dollar (replaced) 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_0742E18258B7 quarterly operating income 1,016,500,000 United States dollar (replaced) 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_7BB6A57A5F50 quarterly research and development 1,085,300,000 United States dollar (replaced) 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_03FC6245728F quarterly revenue 3,158,100,000 United States dollar (replaced) 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_4CC63E98652A total assets 30,657,500,000 United States dollar (replaced) 2023-06-30 to 2023-09-30 sec.gov, 1 source, claim clm_C2064E6D19CF total equity 24,017,900,000 United States dollar (replaced) March · 7 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_7E7BB784381A cash and equivalents 3,916,300,000 United States dollar (replaced) 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_802196BED548 quarterly net income 817,800,000 United States dollar (replaced) 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_D8EB51091FB4 quarterly operating income 946,700,000 United States dollar (replaced) 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_7DFE5AEE2C50 quarterly research and development 1,101,200,000 United States dollar (replaced) 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_179FAEBC31F3 quarterly revenue 3,162,100,000 United States dollar (replaced) 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_0963A3E9D139 total assets 30,059,900,000 United States dollar (replaced) 2023-03-31 to 2023-06-30 sec.gov, 1 source, claim clm_E4AE0A080B44 total equity 23,495,200,000 United States dollar (replaced) Earlier years, each on its own page: 2022 , 2021 , 2020 , 2019 , 2018 , 2017 , 2016 , 2015 , 2014 , 2013 , 2012 , 2011 , 2010 , 2009 , 2008 , 2007 , 1995 , 1988 , undated
/timelines/regeneron-pharmaceuticals.md /v1/timelines/regeneron-pharmaceuticals